PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Stryker Corporation

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Stryker Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 6.2 times. Higher than 90% of Healthcare companies in United States.
  • Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.

Where $100 of sales goes

$80Operating costs$2.4Interest$13Net profit$5.1Paid as dividends

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

$138

Over the last 3 years, every $100 of reported profit came with $138 of operating cash.

Lower than 60% of Healthcare companies in United States.

Self-Funding Ratio

6.2×

Over the last 3 years its own operating cash covered its investment spending (capex) 6.2 times.

Higher than 90% of Healthcare companies in United States.

Cash Locked Ratio

$27

For every $100 of sales, $27 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $30 tied up three years earlier.

More money tied up than 58% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 85% of Healthcare companies in United States.

Growth Efficiency Ratio

$13

Sales grew 36% in 3 years; of every extra $100 of sales, $13 became extra profit.

Lower than 56% of Healthcare companies in United States.

Asset Productivity Ratio

+36% / +30%

In 3 years sales changed by +36% while total assets changed by +30%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

5.0×

Debt due within a year is covered 5.0 times by its yearly operating cash.

Higher than 80% of Healthcare companies in United States.

Cash Cushion Ratio

−10%

Debt, after subtracting cash, equals 10% of its market value (net debt).

Lower than 79% of Healthcare companies in United States.

Tangible Assets Ratio

48%

Of every $100 the company owns, $48 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 83% of Healthcare companies in United States.

Tangible Net Worth Ratio

Negative

Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.

Less tangible than 76% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+1%

Share count rose 1% in 3 years, so each share's slice of the company became smaller. Dividends paid equalled 39% of profit over the same period.

Smaller rise in share count than 83% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Stryker Corporation owes $0.50 for every $1 it owns. Net profit rose 8% in the year to Dec 2025, and grew 11% a year on average over 3 years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

31.8

Investors pay $31.8 for every $1 of Stryker Corporation's yearly profit, higher than 59% of Healthcare companies in United States.

P/B ratio

4.91

The share price is 4.91 times Stryker Corporation's book value per share, higher than 71% of Healthcare companies in United States.

Market cap

$117.8 B

The total market value of all of Stryker Corporation's shares at today's price (share price × number of shares), larger than 98% of Healthcare companies in United States. PosiCap size class: Tito Cap.

Net worth (book value)

$24.0 B

What Stryker Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$62.54

Net worth divided by the number of shares. The share price of $307.08 is 4.9 times this, which is the P/B above.

Return on equity (ROE)

16.5%

Stryker Corporation earned 16.5% on its shareholders' money over the last year, higher than 88% of Healthcare companies in United States.

Owes vs Owns

0.50×

Stryker Corporation owes $0.50 for every $1 it owns (low), higher than 56% of Healthcare companies in United States.

Dividend yield

1.18%

Stryker Corporation pays 1.18% of its share price as dividends a year, higher than 55% of dividend-paying Healthcare companies in United States.

Revenue growth

+11%

Revenue rose 11% in the year to Dec 2025, and grew 11% a year on average over 3 years.

Profit growth

+8%

Net profit rose 8% in the year to Dec 2025, and grew 11% a year on average over 3 years.

Profit margin

12.9%

Stryker Corporation keeps $13 of every $100 of revenue as net profit.

Cash quality

1.6×

Cash from Stryker Corporation's business was 1.6× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

8.3×

Stryker Corporation's operating profit covered its interest costs 8.3 times in the year to Dec 2025.

Cash vs debt

Net debt

Stryker Corporation had $11.8 B more debt than cash (net debt) at Dec 2025.

Questions

What is Stryker Corporation's P/E ratio?

Investors pay $31.8 for every $1 of Stryker Corporation's yearly profit, higher than 59% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Stryker Corporation: $117.8 B ÷ $24.0 B (30 Jun 2026) = 4.9.

What is Stryker Corporation's return on equity?

Stryker Corporation earned 16.5% on its shareholders' money over the last year, higher than 88% of Healthcare companies in United States.

How much does Stryker Corporation owe compared with what it owns?

Stryker Corporation owes $0.50 for every $1 it owns (low), higher than 56% of Healthcare companies in United States.

Does Stryker Corporation pay a dividend?

Yes. Stryker Corporation pays 1.18% of its share price as dividends a year, higher than 55% of dividend-paying Healthcare companies in United States.

Is Stryker Corporation's revenue growing?

Revenue rose 11% in the year to Dec 2025, and grew 11% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.